Therapeutic Specialties Archives | Page 11 of 28 | Certara

Publication

Pharmacokinetics of Praziquantel in Schistosoma Mansoni- and Schistosoma Haematobium-infected School- and Preschool-aged Children

CertaraJune 4, 2018

Publication

Population Pharmacokinetics of Vancomycin in Patients Undergoing Allogeneic Hematopoietic Stem-cell Transplantation

CertaraMay 15, 2018

Publication

A Randomized, First-in-human, Healthy Volunteer Trial of Sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway

CertaraMay 8, 2018

Publication

Pharmacokinetic Properties of a Sufentanil Sublingual Tablet Intended to Treat Acute Pain

CertaraMay 1, 2018

Publication

Metformin Treatment of Type 2 Diabetes Mellitus in Pregnancy: Update on Safety and Efficacy

CertaraApril 25, 2018

Blog

Using M&S to Evaluate Oncology Drug Dosing

There are numerous challenges in developing oncology drugs: (1) they are often very toxic which…

CertaraApril 13, 2018

Publication

Population Pharmacokinetics of Intravenous Linezolid in Premature Infants

CertaraApril 9, 2018

Publication

Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations

CertaraApril 1, 2018

Publication

An Analysis on Distribution and Inter-relationships of Biomarkers Under Rivaroxaban in Japanese Patients with Non-valvular Atrial Fibrillation (CVI ARO 1)

CertaraMarch 15, 2018

On-Demand Webinar

Using Virtual Twin® Technology to Predict Drug Exposure in Individual Patients

In this webinar, Dr. Tom Polasek, a clinical pharmacologist at Certara Strategic Consulting, explained how…

CertaraMarch 8, 2018

© 2025 Certara. All Rights Reserved. | Legal | Privacy policy